Dublin, July 13, 2018 (GLOBE NEWSWIRE) -- The "Global Markets for Media, Sera and Reagents in Biotechnology" report has been added to ResearchAndMarkets.com's offering.

The Global Market will Grow from Nearly $3.6 Billion in 2016 to $4.6 Billion by 2021 at a CAGR of 5.5% Between 2016 and 2021.

This report highlights the current and future market potential of culture media, sera and reagents used in cell culture along with a detailed analysis of the competitive environment, regulatory scenario, and technological advancement, and patent analysis, drivers, restraints, opportunities and trends in market growth. The report also covers market projections to 2023 and market shares for key market players.

Report Scope

• Detailed overview and industry analysis of the global markets for media, sera and reagents used in cell culture within the biotechnology industry
• Country specific data and analysis for United States, Canada, Mexico, Germany, U.K., France, China, India, Japan, Middle East and Africa
• Quantification of market potential by various segments of the media, sera and reagents as well as composition formula, geographical regions and end users
• Assessment of the market dynamics and elaboration on the influence of competitive environment, regulatory scenario, technological advancement, and the economic factors that are and will shape the marketplace
• Information on different types of cell cultures and products from cell culture technology as well as the advantages and disadvantages for the use of various types of media
• Discussion covering the applications of cell culture technology with an emphasis on usage in the research, production, and contract segments
• Company profiles of major players in the industry, including Athena Environmental Science, Inc., Becton, Dickinson and Company, CellGenix, GE Healthcare, Lonza, and Thermo Fisher Scientific, Inc.

Companies Featured

• Athena Environmental Sciences, Inc.
• Atlanta Biologicals (Bio-Techne Corp.)
• Becton, Dickinson And Company
• Biowest
• Bovogen Biologicals Pty Ltd.
• Cell Culture Technologies
• Cellgenix Gmbh
• Corning Incorporated
• Fujifilm Holdings Corp.
• GE Healthcare
• Gemini Bio-Products, Inc.
• Lonza
• Merck Kgaa
• Miltenyi Biotec
• Peprotech, Inc.
• Promocell Gmbh
• Reprocell, Inc.
• Sartorius AG
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.

Key Topics Covered

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Information Sources
• Methodology
• Geographic Breakdown
• Analyst's Credentials
• Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

• Market Definitions
• Adherent Cell Culture
• Carcinogenesis
• Cell Culture
• Cell Line
• Continuous Cell Line
• Cryopreservation
• Culture Media
• Eukaryotes
• Finite Cell Lines
• Mammalian Cell Line
• Monolayer Sloughing
• Mutagenesis
• Osmolality
• Phosphorylation
• Prokaryotes
• Serum
• Subculture
• Suspension Culture
• Zwitterion
• Historical Background of Cell Culture Evolution
• Types of Cell Culture
• Primary Culture
• Secondary Culture
• Morphology of Cells in Culture
• Cell Culture Contaminations and Quality Controls
• Cell Culture Contamination
• Quality Controls in Cell Culture
• Basic Components of Culture Media
• Buffering Systems
• Phenol Red
• Inorganic Salts
• Amino Acids
• Carbohydrates
• Proteins and Peptides
• Fatty Acids and Lipids
• Vitamins
• Trace Elements
• Media Supplements
• Antibiotics
• Serum
• Application of Cell Culture

Chapter 4 Market Dynamics

• Market Drivers
• Growing Demand for Cell Culture Products from Biopharmaceutical Companies for the Production of Biologics and Biosimilars
• Technological Advancements in Cell Culture & Growing Adoption Rates of Cell Culture-Based Vaccines
• Remarkable Expansion of Cell Cultures Across a Wide Array of Applications
• Rising Investment in R&D & Growing Demand for Regenerative Medicines
• Market Restraints
• Ethical Issues in Stem Cell Research & Regulatory Constraints on Biopharmaceuticals
• Dearth of Skilled Technicians and Poor Infrastructure for Cell Culture Technology
• Market Opportunities
• Rising Demand for 3D Cell Cultures
• Increase in Drug Discovery Activities and Growing CRO Markets in Emerging Economies

Chapter 5 Market Breakdown by Product Type

• Global Market of Media, Sera and Reagents in Biotechnology, by Product Type
• Market Analysis
• Market Revenue
• Media
• Market Analysis
• Market Revenue
• Serum-free Media and Serum-requiring Media
• Powdered and Liquid Media
• Classical Media and Specialty Media
• Sera
• Market Analysis
• Market Revenue
• Bovine Sera/Fetal Bovine Serum
• Other Sera
• Reagents
• Market Analysis
• Market Revenue
• Biological Response Modifiers (BRMs)
• Cell Dissociation Reagents
• Other Reagents

Chapter 6 Market Breakdown by End User

• Global Market for Media, Sera and Reagents in Biotechnology, by End Users
• Production Segment
• Market Analysis
• Market Revenue
• Research Segment
• Market Analysis
• Market Revenue
• Contract Segment
• Market Analysis
• Market Revenue
• Others Segment
• Market Analysis
• Market Revenue

Chapter 7 Market Breakdown by Region

• Global Market for Media, Sera and Reagents in Biotechnology, by Region
• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Rest of Europe
• Asia-Pacific Region
• Japan
• China
• India
• Australia and New Zealand
• Rest of Asia-Pacific
• South America
• Middle East & Africa

Chapter 8 Regulatory Scenarios

• Introduction
• Biological License Applications
• Biological Administrative Actions
• Recall
• Sera-Regulatory Scenario

Chapter 9 Recent Technological Advancements in the Cell Culture Industry

Chapter 10 Patent Analysis

• Patents by Year
• Patents by Type
• Patents by Company
• Patents by Country
• Patents by Assignee

Chapter 11 Industry Structure

• Market Players and Market Structure Analysis
• Media
• Serum-free Media
• Serum-requiring Media
• Powdered Media
• Liquid Media
• Classical Media
• Specialty Media
• Sera
• Reagents

Chapter 12 Company Profiles

• ATHENA ENVIRONMENTAL SCIENCES, INC.
• Company Overview
• Product Portfolio
• ATLANTA BIOLOGICALS (BIO-TECHNE CORP.)
• Company Overview
• Financials
• Product Portfolio
• Development and Strategies
• BECTON, DICKINSON AND COMPANY
• Company Overview
• Financials
• Product Portfolio
• Development and Strategies
• BIOWEST
• Company Overview
• Product Portfolio
• Development and Strategies
• BOVOGEN BIOLOGICALS PTY LTD.
• Company Overview
• Product Portfolio
• CELL CULTURE TECHNOLOGIES
• Company Overview
• Product Portfolio
• Development and Strategies
• CELLGENIX GMBH
• Company Overview
• Product Portfolio
• Development and Strategies
• CORNING INCORPORATED
• Company Overview
• Financials
• Product portfolio
• Development and Strategies
• FUJIFILM HOLDINGS CORP.
• Company Overview
• Financials
• Product Portfolio
• Development and Strategies
• GE HEALTHCARE
• Company Overview
• Financials
• Product Portfolio
• Development and Strategies
• GEMINI BIO-PRODUCTS, INC.
• Company Overview
• Product Portfolio
• LONZA
• Company Overview
• Financials
• Product Portfolio
• Development and Strategies
• MERCK KGAA
• Company Overview
• Financials
• Product Portfolio
• Development and Strategies
• MILTENYI BIOTEC
• Company Overview
• Product Portfolio
• PEPROTECH, INC.
• Company Overview
• Product Portfolio
• PROMOCELL GMBH
• Company Overview
• Product Portfolio
• Development and Strategies
• REPROCELL, INC.
• Company Overview
• Product Portfolio
• Development and Strategies
• SARTORIUS AG
• Company Overview
• Financials
• Product portfolio
• Development and Strategies
• TAKARA BIO, INC.
• Company Overview
• Financials
• Product Portfolio
• Development and Strategies
• THERMO FISHER SCIENTIFIC, INC.
• Company Overview
• Financials
• Product Portfolio
• Development and Strategies

Chapter 13 Appendix: Abbreviations

For more information about this report visit https://www.researchandmarkets.com/research/wk3d45/media_sera_and?w=12

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Biotechnology